aspirin has been researched along with atorvastatin in 156 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.64) | 18.2507 |
| 2000's | 39 (25.00) | 29.6817 |
| 2010's | 90 (57.69) | 24.3611 |
| 2020's | 26 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cooper, A; Kratzer, S; Pershad, A | 1 |
| Ashby, DT; Conditt, G; Dangas, G; Hirose, M | 1 |
| Baumgartner, RW; Georgiadis, D | 1 |
| Khan, BV; Khan, QA; Lauten, WB; Lerakis, S; Parthasarathy, S; Rahman, ST; Rajagopalan, S | 1 |
| Böhm, M; Fries, R | 1 |
| Denman, R; Martin, PT | 1 |
| Karas, RH; Kimmelstiel, C; Pourati, I; Rand, W | 1 |
| Ruef, J | 1 |
| Fang, CH; Li, JJ | 1 |
| Daida, H; Kurata, T; Miyauchi, K; Okazaki, S; Sato, H; Shimada, K; Yokoyama, T | 1 |
| Bates, ER; Lau, WC | 1 |
| Curtiss, FR | 1 |
| Arad, Y; Guerci, AD; Newstein, D; Roth, M; Spadaro, LA | 1 |
| Beck, T; Burgstahler, C; Heuschmid, M; Kopp, AF; Kuettner, A; Reimann, A; Schroeder, S | 1 |
| Khor, TO; Kong, AN; Kopelovich, L; Rao, CV; Reddy, BS; Steele, VE; Wang, CX; Zheng, X | 1 |
| Hatipoglu, SE; Iltimur, K; Tacar, O; Tuncer, CM | 1 |
| Agarwal, S; Coakely, M; Coakley, M; Mallett, S; Reddy, K; Riddell, A | 1 |
| Li, M; Ren, H; Zhang, Y; Zhu, X | 1 |
| Birnbaum, Y; Freeberg, SY; Huang, MH; Lin, Y; Perez-Polo, JR; Uretsky, BF; Ye, Y | 1 |
| Billinger, M; Cook, S; Haeberli, A; Hess, OM; Meier, B; Togni, M; Wenaweser, P; Windecker, S | 1 |
| Birnbaum, Y; Huang, MH; Lin, Y; Lui, CY; Martinez, JD; Perez-Polo, JR; Uretsky, BF; Ye, Y | 1 |
| Arima, J; Iguro, Y; Kariyazono, H; Masuda, H; Nakamura, K; Sakata, R; Yamada, K | 1 |
| Nidorf, M; Thompson, PL | 1 |
| Nisanci, Y; Oflaz, H; Pamukcu, B; Tirnaksiz, E | 1 |
| Chen, MH; D'Amico, AV; Kantoff, PW | 1 |
| De Angelis, S; De Lorenzo, A; Di Daniele, N; Di Renzo, L; Miani, N; Noce, A; Tozzo, C | 1 |
| Kumar, V; Shah, RP; Singh, S | 1 |
| Bonnaire, B; Bugnicourt, JM; Garcia, PY; Godefroy, O; Lefranc, M; Lepage, L | 1 |
| Xiao, H; Yang, CS | 1 |
| Kasyanova, O; Shpektor, A; Vasilieva, E | 1 |
| Acar, G; Nacar, AB; Sökmen, G; Tuncer, C | 1 |
| Todd, DJ | 1 |
| Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W | 1 |
| Hanhart, J; Koskas, P; Le Mer, Y; Obadia, M; Paques, M; Sahel, JA | 1 |
| Aarts, JC; Bax, L; Beek, FJ; Beutler, JJ; Braam, B; Buskens, E; de Haan, MW; Doorenbos, CJ; Huysmans, FT; Kouwenberg, HJ; Kroon, AA; Mali, WP; Pattynama, PM; Plouin, PF; Postma, CT; Rabelink, TJ; Raynaud, A; Reekers, JA; Rutten, MJ; Schultze Kool, LJ; van de Ven, PJ; van den Meiracker, AH; van Montfrans, GA; Vroegindeweij, D; Woittiez, AJ | 1 |
| Ak, K; Arsan, S; Eksioglu-Demiralp, E; Iqbal, O; Isbir, S; Tetik, S; Yardimci, T | 1 |
| Chakrabarti, D; Saikia, PK | 1 |
| Geng, L; Li, ZX; Meng, XP; Wang, SX; Yin, CY; Zhang, JC | 1 |
| Fuset, MP; Moscardó, A; Ruano, M; Santos, MT; Valles, J | 1 |
| Derksen, C; Khan, K; Saqqur, M; Sebastian, J | 1 |
| Buerke, M; Chen, L; Frister, A; Hofmann, B; Lautenschläger, M; Loppnow, H; Luther, T; Müller-Werdan, U; Rose-John, S; Schlitt, A; Silber, RE; Song, N; Werdan, K; Zhang, L | 1 |
| Berger, M; Krane, V; Lilienthal, J; Schambeck, C; Wanner, C; Winkler, K | 1 |
| Eckel, RH | 1 |
| Adámek, T; Alusik, S; Lejsková, M; Paluch, Z | 1 |
| Dougu, N; Nukui, T; Taguchi, Y; Takashima, S; Tanaka, K; Toyoda, S | 1 |
| Aslani, A; Cheng, KK; Gharravi, M; Khoshnia, M; Larijani, B; Malekzadeh, F; Malekzadeh, R; Marshall, T; Nateghi, A; Pourshams, A; Rastegarpanah, M; Salahi, R; Semnani, S; Thomas, GN | 1 |
| Abrecht, L; Eshtehardi, P; Haeberli, A; Hess, OM; Meier, B; Schmidlin, K; Wenaweser, P; Windecker, S; Zwahlen, M | 1 |
| Berk, M; Henry, MJ; Jacka, FN; Kotowicz, MA; Nicholson, GC; Pasco, JA; Williams, LJ | 1 |
| Holman, JR; Jamieson, B; Lin, V | 1 |
| Charles, J; Miller, G; Pan, Y | 1 |
| Boncler, M; Czyz, M; Luzak, B; Rysz, J; Rywaniak, J; Stanczyk, L; Watala, C; Wilk, R | 1 |
| Sillence, D; Tchan, M | 1 |
| Bramanti, P; Calabrò, RS; Gervasi, G; Pezzini, A; Pollicino, P | 1 |
| Choi, Y; Kim, DE; Lee, DK; Park, JE; Schellingerhout, D; Shon, SM | 1 |
| Shinohara, Y | 1 |
| Sankar, AS; Venkappaya, D; Vetrichelvan, T | 1 |
| Binning, MJ; Darkhabani, Z; Levy, EI; Mokin, M; Siddiqui, AH | 1 |
| Luzak, B; Rywaniak, J; Stanczyk, L; Watala, C | 1 |
| Bragagnolo, JC; Catalano, H; Comignani, PD; Cornejo Pucci, E; Herrera, L; Igarzabal, C; Laffaye, N; Macchia, A; Mariani, JA; Nicolucci, A; Scazziota, AS; Tognoni, G | 1 |
| Ahn, JH; Bliden, KP; Gho, EH; Gurbel, PA; Hwang, JY; Hwang, SJ; Jeong, YH; Kim, S; Kwak, CH; Kwon, TJ; Park, JR; Park, Y; Tantry, US | 1 |
| Araújo, AC; Jorge, VC; Noronha, C; Panarra, A; Riso, N; Vaz Riscado, M | 1 |
| Fisher, EA; Fisher, R; Peters, MR | 1 |
| Chen, ZC; Lou, M; Shi, ZH; Sun, JZ | 1 |
| Hennessey, MJ; Murphy, SM; Ryan, D | 1 |
| Ali, S; Iyer, RS; Krishnan, M; Kumar, S | 1 |
| Buszman, PE; Buszman, PP; Kiesz, RS; Konkolewska, MD; Martin, JL; Radvany, MG; Szymanski, R; Wiernek, BK; Wiernek, SL | 1 |
| Foroughipour, M; Nikbin, Z; Pezeshki Rad, M; Sahebari, M; Shoeibi, A | 1 |
| Latorre, A; Madrid, I; Moscardó, A; Santos, MT; Vallés, J | 1 |
| Spence, JD | 1 |
| Battula, R; Betha, MR; Cheerla, R; Gadiko, C; Khan, SM; Nakkawar, M; Thota, S; Tippabhotla, SK; Vobalaboina, V; Yergude, S | 1 |
| Hattori, N; Oji, Y; Sekiguchi, K; Tanaka, R; Tanaka, Y; Tomizawa, Y; Yamashiro, K | 1 |
| Brown, MM | 1 |
| Franzoni, F; Gaudio, C; Greco, C; Marazzi, G; Pelliccia, F; Polacco, M; Rosano, G; Speziale, G; Spoletini, I; Vitale, C | 1 |
| Albers, GW; Tai, WA | 1 |
| Hegazy, ND; Issa, MM; Nejem, RM; Shanab, AA; Stefan-van Staden, RI | 1 |
| de Ceuninck, M; Trenson, S | 1 |
| Kartashova, EA; Romantsov, MG; Sarvilina, IV | 1 |
| Chen, T; Liang, L; Shen, Y; Yan, Y; Yuan, Y; Zhong, C | 1 |
| Cheng, KK; Etemadi, A; Hemming, K; Jaafari, E; Khoshnia, M; Majed, M; Malekzadeh, F; Malekzadeh, R; Marjani, H; Marshall, T; Merat, S; Mohammadifard, N; Naemi, M; Nateghi, A; Navabakhsh, B; Ostovaneh, MR; Pourshams, A; Poustchi, H; Sadeghi, M; Sarrafzadegan, N; Thomas, GN | 1 |
| Luo, YH; Wang, YY; Xie, YM; Yang, W; You, L; Zhuang, Y | 1 |
| Akhalaque Ahmad, RA; Chatpalliwar, VA; Chhajed, SS; Porwal, PK | 1 |
| Aboul-Enein, HY; Issa, MM; Nejem, RM; Van Staden, RI | 1 |
| Abdel-Rahman, I; Murphy, C | 1 |
| Bonham, L; Donnelly, RF; Hughes, CM; Quinn, HL | 1 |
| Hemming, K; Jafari, E; Khoshnia, M; Malekzadeh, R; Marshall, T; Merat, S; Nateghi, A; Poustchi, H; Radmard, AR; Shiravi Khuzani, A | 1 |
| Ahmed, Z; Bajwa, A; Bhardwaj, B; Laster, SB; Magalski, A | 1 |
| Barbieri, L; Bellomo, G; De Luca, G; Marino, P; Nardin, M; Pergolini, P; Rolla, R; Sartori, C; Suryapranata, H; Verdoia, M | 1 |
| Barrios, V; Escobar, C | 1 |
| Dhopeshwarkar, N; Goss, F; Lai, K; Rozenblum, R; Sa'adon, R; Seger, DL; Topaz, M; Zhou, L | 1 |
| Castellano, JM; Fuster, V; Tamargo, J | 1 |
| Liu, W; Wu, S; Zhou, Y | 1 |
| Li, Y; Liao, Q; Liu, Q; Lu, Z; Niu, Z; Wang, M; Yao, L; Zhao, Y; Zong, Y | 1 |
| Einecke, D | 1 |
| Abarca, B; González-Juanatey, JR; Llisterri, JL; Lobos, JM; Mostaza, JM | 1 |
| Stiefelhagen, P | 1 |
| Ahmad, MA; Akhtar, M; Mujeeb, M; Najmi, AK | 1 |
| Barrios, V; Castellano, JM; Cosin-Sales, J; Fuster, V; Gracia, A; Kaskens, L; Ruiz, JE; Zsolt, I | 1 |
| Lekshmi Sheela, D; Manalil, JJ; Narayanankutty, A; Nazeem, PA; Raghavamenon, AC | 1 |
| Berringer, R; Wonnacott, D | 1 |
| Du, Z; Farischon, C; Goodin, S; He, Y; Huang, H; Li, D; Zhang, K; Zheng, X | 1 |
| Kochubiei, O; Ovrakh, T; Serik, S | 1 |
| Ahn, CM; Cheong, SS; Cho, DK; Cho, YH; Choi, D; Her, AY; Hong, MK; Im, E; Jang, Y; Kang, WC; Kim, BK; Kim, JS; Kim, YH; Ko, YG; Lee, K; Shin, DH; Suh, Y; Yoo, SY; Yun, KH | 1 |
| Apola, A; Hubicka, U; Kwiecień, A; Maślanka, A; Opoka, W; Stolarczyk, M | 1 |
| Cameron, SJ; Doyle, A; Mix, D; Parsons, MR; Stoner, MC | 1 |
| Jia, PP; Liu, H; Wang, GQ; Xie, YM; Zhang, Y; Zhuang, Y | 2 |
| Brohi, H; Kumar, R; Mughul, A | 1 |
| Andrés Marín, N; Antigüedad-Muñoz, J; Arenaza Choperena, G; de la Riva, P; Fernández-Eulate, G; Martínez Zabaleta, M; Moreno Valladares, M; Muñoz Lopetegi, A | 1 |
| Agrawal, Y; Kalavakunta, JK; Zoltowska, DM | 1 |
| Pitts-Tucker, T; Small, J | 1 |
| Adnan, S; Ali, S; Ali, T; Farooq, M; Gill, SA; Masood, Z; Saleem, H; Shabbir, M; Shahid, N; Waqar, K | 1 |
| Egan Benova, T; Kukreja, RC; Kura, B; Slezak, J; Szeiffova Bacova, B; Tribulova, N; Viczenczova, C; Yin, C | 1 |
| Davda, N; Osman, C | 1 |
| El-Din Aly El-Waseef, DA; El-Kharashi, OA; Mohamed, DI; Nabih, ES | 1 |
| Dalugama, C; Gawarammana, IB | 1 |
| Aoi, S; Golfeyz, S; Harrington, M; Kobayashi, T | 1 |
| Finsterer, J; Stollberger, C | 1 |
| Chouksey, D; Dani, R; Dube, M; Dubey, A | 1 |
| Mohebbati, R; Niazmand, S; Paseban, M; Sahebkar, A; Sathyapalan, T | 1 |
| Chandra, A; Cheng, Z; Ding, Y; Du, H; Geng, X; Tong, Y; Zhu, H | 1 |
| Zhang, C; Zhang, Z | 1 |
| Haas, MRC; Haas, NL; Nicholson, A | 1 |
| Dulak, J; Florczyk-Soluch, U; Frołow, M; Józkowicz, A; Kachamakova-Trojanowska, N; Klóska, D; Markiewicz, J; Niżankowski, R; Nowak, WN; Stępniewski, J; Taha, H; Walter, Z | 1 |
| Boffetta, P; Brennan, P; Cheng, KK; Etemadi, A; Fazel, A; Gharavi, A; Hemming, K; Kamangar, F; Khoshnia, M; Majed, M; Malekzadeh, F; Malekzadeh, R; Marshall, T; Merat, S; Mohammadifard, N; Naemi-Tabiei, M; Nalini, M; Nateghi, A; Navabakhsh, B; Ostovaneh, MR; Pourshams, A; Poustchi, H; Roshandel, G; Sadeghi, M; Sarrafzadegan, N; Thomas, N | 1 |
| González-Juanatey, JR; Oudovenko, N; Tamargo, J; Torres, F; Weisser, B | 1 |
| Chang, WL; Clapper, ML; Cooper, HS | 1 |
| Amidzic, A; Tiro, N | 1 |
| Mehta, A; Sperling, LS; Wells, BJ | 1 |
| Barkoudah, E; Klein, JP; Mueller, AA; Tarter, LL; Vaidya, A | 1 |
| Abtahi, F; Anushiravani, A; Fattahi, MR; Gandomkar, A; Malekzadeh, F; Malekzadeh, R; Malekzadeh, Z; Merat, S; Moghadami, M; Mohammadkarimi, V; Moini, M; Mortazavi, R; Poustchi, H; Sadeghi Boogar, S; Sepanlou, SG | 1 |
| Gao, YL; Guo, JJ; Wang, M; Wang, ZY; Yu, XF | 1 |
| Bhati, S; Bhatnagar, S; Bhushan, S; Deepti, S; Dwivedi, T; Garg, R; Ghati, N; Guleria, R; Gupta, R; Mahendran, M; Mani, K; Mohan, A; Roy, A; Saxena, A; Thakur, A; Tiwari, P | 1 |
| Alonso-Canovas, A; Chico-García, JL; Cruz-Culebras, A; de Felipe Mimbrera, A; García-Madrona, S; Gómez-López, A; Masjuan, J; Matute-Lozano, C; Natera-Villalba, E; Ros-Castelló, V; Sánchez-Sánchez, A; Vera-Lechuga, R | 1 |
| Ding, Y; Feng, X; Lin, W; Zhao, T; Zhou, C | 1 |
| Chen, Y; Fu, B; Li, P | 1 |
| Choulerton, J; Guha, N; Squires, R | 1 |
| Fujibuchi, W; Kobayashi, K; Panina, Y; Sone, H; Yamane, J | 1 |
| Araújo, PSR; Godoi, ET; Lacerda, HR; Leite, KME; Santos Junior, GGD; Vasconcelos, AF | 1 |
| Bhandari, S; Dadhwal, DS; Dogra, V; Gupta, S; Raina, S; Sharma, A; Sharma, C; Singh, B; Sood, V | 1 |
| Bhatnagar, S; Deepti, S; Dwivedi, T; Ghati, N; Guleria, R; Gupta, R; Kumar, D; Mahendran, M; Mani, K; Mohan, A; Prasad, K; Saxena, A; Thakur, A; Tiwari, P | 1 |
| Tang, X; Wang, L | 1 |
| Chen, M; Li, D; Liu, J; Liu, W; Ma, Y; Sheng, Z; Wang, X; Wu, Y; Xu, X; Zhao, D; Zheng, X | 1 |
| Alonso Garcia, A; Andres, V; Barczi, G; Baviera, M; Beghi, E; Bejot, Y; Bhatt, DL; Bueno, H; Castellano, JM; Colivicchi, F; Collier, T; Cordero, A; Di Fusco, SA; Doehner, W; Domingo-Fernández, A; Ecarnot, F; Fernandez Alvira, JM; Fernandez Ferro, J; Fernandez-Ortiz, A; Foresta, A; Fuster, V; Ibañez, B; Kasprzak, M; Linhart, A; Lopez, N; Lozano, I; Lubanda, JC; Marin Ortuño, F; Merkely, B; Meyer, A; Ojeda-Fernandez, L; Owen, R; Perel, P; Pocock, SJ; Ponikowski, P; Proietti, M; Quesada, AJ; Rodriguez-Manero, M; Roncaglioni, MC; Sanchez, PL; Schiele, F; Schoos, MM; Simon, T; Van de Werf, F; Vazquez Rodriguez, JM; Vivas, D | 1 |
| Amarenco, P; Bath, PM; Chen, W; Gao, Y; Han, S; Jing, J; Johnston, SC; Li, H; Liu, L; Meng, X; Pan, Y; Wang, C; Wang, T; Wang, Y; Yang, Y; Zhao, X | 1 |
| Dong, B; Dong, S; Li, L; Liu, Q; Shen, J; Yang, K; Zhao, Y; Zhou, X; Zhu, D | 1 |
| Abdallah, NA; El-Awady, MI; El-Brashy, AM; Ibrahim, FA | 1 |
| Chen, C; Chen, G; Cui, J; Liao, Y; Ming, J; Song, W; Wang, X; Wang, Z; Xu, K | 1 |
| Bellomo, T; Boada, AE; Dua, A; Goudot, G; Hall, RP; Jessula, S; Kukreja, N; Lee, I; Majumdar, M; Parmar, G; Suarez Ferreira, SP | 1 |
| Baker, JV; Gorelick, RJ; Krishnan, S; Laidlaw, E; Lisco, A; Manion, M; Migueles, SA; Mystakelis, HA; Poole, A; Rupert, A; Sereti, I; Welker, JL; Wilson, E | 1 |
| Cassola, N; Clezar, CN; Flumignan, CD; Flumignan, RL; Nakano, LC; Trevisani, VF | 1 |
14 review(s) available for aspirin and atorvastatin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Secondary prevention after ischemic stroke].
Topics: Administration, Oral; Angioplasty, Balloon; Anticholesteremic Agents; Anticoagulants; Aspirin; Atorvastatin; Carotid Stenosis; Endarterectomy, Carotid; Female; Fibrinolytic Agents; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Placebos; Platelet Aggregation Inhibitors; Prospective Studies; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Smoking Prevention; Stents; Stroke; Vertebral Artery Dissection | 2003 |
[Update cardiology 2001/2002-part II. From unstable coronary syndrome to terminal heart failure].
Topics: Abciximab; Acute Disease; Adrenergic beta-Antagonists; Angina, Unstable; Antibodies, Monoclonal; Anticholesteremic Agents; Arrhythmias, Cardiac; Aspirin; Atorvastatin; Clopidogrel; Defibrillators, Implantable; Double-Blind Method; Fibrinolytic Agents; Heart Failure; Heart Septal Defects, Atrial; Heart Transplantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Myocardial Infarction; Placebos; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrroles; Quality of Life; Randomized Controlled Trials as Topic; Regeneration; Risk Factors; Syndrome; Ticlopidine; Time Factors; Tirofiban; Tyrosine | 2003 |
[Interactions of statins with antithrombotic drugs].
Topics: Animals; Anticholesteremic Agents; Aspirin; Atorvastatin; Cardiovascular Diseases; Clopidogrel; Controlled Clinical Trials as Topic; Drug Interactions; Drug Therapy, Combination; Fibrinolytic Agents; Follow-Up Studies; Hemostasis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Platelet Aggregation Inhibitors; Pravastatin; Primary Prevention; Pyrroles; Rats; Ticlopidine; Time Factors | 2004 |
Combination regimen with statins and NSAIDs: a promising strategy for cancer chemoprevention.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Atorvastatin; Celecoxib; Colorectal Neoplasms; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Evidence-Based Medicine; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Meta-Analysis as Topic; Neoplasms; Pravastatin; Pyrazoles; Pyridines; Pyrroles; Randomized Controlled Trials as Topic; Simvastatin; Sulfonamides; Sulindac | 2008 |
Clinical Inquiries: Which drugs should post-MI patients routinely receive?
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Atorvastatin; Clopidogrel; Eplerenone; Heptanoic Acids; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyrroles; Spironolactone; Ticlopidine | 2010 |
[Japanese Guidelines for the Management of Stroke 2009 : important revised points necessary for the neurologist].
Topics: Aspirin; Atorvastatin; Cilostazol; Diabetes Complications; Dyslipidemias; Evidence-Based Medicine; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Japan; Neurology; Physicians; Pioglitazone; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pyrroles; Secondary Prevention; Stroke; Tetrazoles; Thiazolidinediones; Tissue Plasminogen Activator | 2010 |
Aggressive medical therapy alone is not adequate in certain patients with severe symptomatic carotid stenosis.
Topics: Aspirin; Atorvastatin; Carotid Artery Diseases; Clopidogrel; Constriction, Pathologic; Endovascular Procedures; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Platelet Aggregation Inhibitors; Pyrroles; Ticlopidine | 2013 |
Spontaneous coronary artery dissection: the management dilemma continues.
Topics: Adenosine; Adult; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Carbazoles; Carvedilol; Coronary Angiography; Coronary Vessel Anomalies; Diagnosis, Differential; Echocardiography; Electrocardiography; Female; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Propanolamines; Purinergic P2Y Receptor Antagonists; Ticagrelor; Vascular Diseases | 2015 |
Improving cardiovascular protection: focus on a cardiovascular polypill.
Topics: Antihypertensive Agents; Aspirin; Atorvastatin; Cardiovascular Diseases; Drug Combinations; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Medication Adherence; Platelet Aggregation Inhibitors; Ramipril; Simvastatin | 2016 |
The Fuster-CNIC-Ferrer Cardiovascular Polypill: a polypill for secondary cardiovascular prevention.
Topics: Aspirin; Atorvastatin; Cardiovascular Agents; Cardiovascular Diseases; Drug Combinations; Humans; Ramipril; Secondary Prevention | 2015 |
Spontaneous coronary artery dissection: Case report and review of the literature.
Topics: Acute Coronary Syndrome; Adrenergic beta-1 Receptor Antagonists; Adult; Aspirin; Atorvastatin; Clopidogrel; Coronary Angiography; Coronary Vessel Anomalies; Echocardiography; Electrocardiography; Female; Humans; Metoprolol; Platelet Aggregation Inhibitors; Ticlopidine; Vascular Diseases | 2016 |
Dysplastic Aberrant Crypt Foci: Biomarkers of Early Colorectal Neoplasia and Response to Preventive Intervention.
Topics: Aberrant Crypt Foci; Adenoma; Adenomatous Polyposis Coli Protein; Animals; Antineoplastic Agents; Aspirin; Atorvastatin; Carcinogenesis; Catechin; Clinical Trials as Topic; Colon; Colonoscopy; Colorectal Neoplasms; Dietary Supplements; Disease Models, Animal; Humans; Intestinal Mucosa; Lycopene; Mice; Mutation; Treatment Outcome | 2020 |
Pharmacological interventions for asymptomatic carotid stenosis.
Topics: Aspirin; Atherosclerosis; Atorvastatin; Carotid Stenosis; Chlorthalidone; Fluvastatin; Hemorrhage; Humans; Ischemic Stroke; Metoprolol; Pravastatin; Probucol; Rosuvastatin Calcium; Stroke; Warfarin | 2023 |
39 trial(s) available for aspirin and atorvastatin
| Article | Year |
|---|---|
Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.
Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atorvastatin; Cardiovascular Agents; Cholesterol, LDL; Cilostazol; Combined Modality Therapy; Coronary Angiography; Coronary Disease; Female; Follow-Up Studies; Heparin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Pyrroles; Tetrazoles; Ticlopidine; Treatment Outcome; Ultrasonography, Interventional | 2004 |
Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial.
Topics: Aged; alpha-Tocopherol; Antioxidants; Ascorbic Acid; Aspirin; Atorvastatin; Calcinosis; Coronary Artery Disease; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrroles; Tomography, X-Ray Computed | 2005 |
Quantifying the effect of antiplatelet therapy: a comparison of the platelet function analyzer (PFA-100) and modified thromboelastography (mTEG) with light transmission platelet aggregometry.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atorvastatin; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Light; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Pyrroles; Surgical Procedures, Operative; Thrombelastography; Ticlopidine | 2006 |
Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis.
Topics: Aged; Aspirin; Atorvastatin; Clopidogrel; Coronary Restenosis; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Pravastatin; Prospective Studies; Prosthesis Failure; Pyrroles; Stents; Ticlopidine; Treatment Outcome | 2007 |
Effects of atorvastatin and aspirin combined therapy on inflammatory responses in patients undergoing coronary artery bypass grafting.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antithrombins; Aspirin; Atorvastatin; Blood Platelets; Cholesterol; Coronary Artery Bypass; Cytokines; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Inflammation; Male; Middle Aged; P-Selectin; Pyrroles; Receptors, Cytokine; Thrombin; Thromboxane B2; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2006 |
Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease.
Topics: Aspirin; Atorvastatin; Biomarkers; C-Reactive Protein; Colchicine; Coronary Angiography; Coronary Artery Disease; Drug Administration Schedule; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Pyrroles; Treatment Outcome | 2007 |
Effect of high dose statin therapy on platelet function; statins reduce aspirin-resistant platelet aggregation in patients with coronary heart disease.
Topics: Adenosine Diphosphate; Adult; Aged; Aspirin; Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Collagen; Coronary Disease; Diabetes Complications; Drug Resistance; Epinephrine; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Male; Middle Aged; Platelet Aggregation; Platelet Function Tests; Pyrroles; Smoking | 2009 |
The antiplatelet effect of atorvastatin in patients with acute coronary syndrome depends on the hs-CRP level.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Atorvastatin; C-Reactive Protein; Clopidogrel; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrroles; Ticlopidine | 2008 |
Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial.
Topics: Aged; Antihypertensive Agents; Aspirin; Atherosclerosis; Atorvastatin; Combined Modality Therapy; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Middle Aged; Pyrroles; Renal Artery; Renal Artery Obstruction; Stents | 2009 |
Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
Topics: Adenosine Diphosphate; Aged; Aspirin; Atorvastatin; Clopidogrel; Comorbidity; Coronary Artery Bypass; Coronary Disease; Drug Therapy, Combination; Female; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipoproteins, LDL; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Prospective Studies; Pyrroles; Ticlopidine | 2010 |
[Effects of probucol, aspirin and atorvastatin combination therapy upon atherosclerosis].
Topics: Aged; Aspirin; Atherosclerosis; Atorvastatin; Cholesterol, HDL; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hypolipidemic Agents; Lipoproteins, LDL; Male; Matrix Metalloproteinase 9; Middle Aged; Probucol; Pyrroles | 2009 |
Effect of atorvastatin on platelet thromboxane A(2) synthesis in aspirin-treated patients with acute myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atorvastatin; Blood Platelets; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pyrroles; Thromboxane A2; Treatment Outcome | 2009 |
Statins potently reduce the cytokine-mediated IL-6 release in SMC/MNC cocultures.
Topics: Aspirin; Atorvastatin; Cell Separation; Coculture Techniques; Dose-Response Relationship, Drug; Drug Synergism; Heptanoic Acids; HMGB1 Protein; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indomethacin; Interleukin-1; Interleukin-6; Leukocytes, Mononuclear; Lipopolysaccharides; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Pyrroles; Recombinant Proteins; Simvastatin; STAT3 Transcription Factor; Time Factors; Tumor Necrosis Factor-alpha | 2011 |
Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes.
Topics: Aged; Antibodies; Aspirin; Atorvastatin; Cause of Death; Chi-Square Distribution; Death, Sudden; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Germany; Heparin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Kidney Diseases; Logistic Models; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Factor 4; Proportional Hazards Models; Prospective Studies; Pyrroles; Renal Dialysis; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome | 2010 |
A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy ('polypill') on cardiovascular risk factors.
Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Chronic Disease; Double-Blind Method; Drug Combinations; Enalapril; Female; Heptanoic Acids; Humans; Hydrochlorothiazide; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Pyrroles; Risk Factors; Tablets | 2010 |
A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Atorvastatin; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Drug Interactions; Drug Therapy, Combination; Drug-Eluting Stents; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Prosthesis Design; Pyrroles; Switzerland; Ticlopidine; Time Factors; Treatment Outcome | 2010 |
The effect of a platelet cholesterol modulation on the acetylsalicylic acid-mediated blood platelet inhibition in hypercholesterolemic patients.
Topics: Acetylation; Aspirin; Atorvastatin; Blood Platelets; Blood Proteins; Cholesterol; Drug Interactions; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Middle Aged; Pyrroles | 2011 |
Statins but not aspirin reduce thrombotic risk assessed by thrombin generation in diabetic patients without cardiovascular events: the RATIONAL trial.
Topics: Anticholesteremic Agents; Aspirin; Atorvastatin; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibrinolytic Agents; Heptanoic Acids; Humans; Male; Middle Aged; Prospective Studies; Pyrroles; Risk Factors; Thrombin | 2012 |
Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study.
Topics: Adenosine Diphosphate; Aspirin; Atorvastatin; Calcium Channel Blockers; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 CYP3A; Drug Substitution; Drug Therapy, Combination; Female; Fluorobenzenes; Genotype; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Pravastatin; Prospective Studies; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides; Ticlopidine | 2012 |
Bioequivalence of fixed dose combination of atorvastatin 10 mg and aspirin 150 mg capsules: a randomized, open-label, single-dose, two-way crossover study in healthy human subjects.
Topics: Adult; Area Under Curve; Aspirin; Atorvastatin; Capsules; Cross-Over Studies; Drug Combinations; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrroles; Therapeutic Equivalency | 2013 |
Aggressive medical therapy alone is not adequate in certain patients with severe symptomatic carotid stenosis.
Topics: Aspirin; Atorvastatin; Carotid Artery Diseases; Clopidogrel; Constriction, Pathologic; Endovascular Procedures; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Platelet Aggregation Inhibitors; Pyrroles; Ticlopidine | 2013 |
Pharmacodynamic comparison of pitavastatin versus atorvastatin on platelet reactivity in patients with coronary artery disease treated with dual antiplatelet therapy.
Topics: Aged; Aged, 80 and over; Aspirin; Atorvastatin; Clopidogrel; Coronary Artery Disease; Cross-Sectional Studies; Cytochrome P-450 CYP3A; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrroles; Quinolines; Ticlopidine | 2014 |
[The influence of citoflavin on molecular mechanisms of hypertensive encephalopathy development in patients with systolic arterial hypertension].
Topics: Aged; Aged, 80 and over; Amlodipine; Aspirin; Atorvastatin; Blood Pressure; Blood Proteins; Drug Combinations; Drug Therapy, Combination; Echocardiography; Female; Flavin Mononucleotide; Hemodynamics; Heptanoic Acids; Humans; Hypertension; Hypertensive Encephalopathy; Inosine Diphosphate; Male; Neuroprotective Agents; Niacinamide; Pyrroles; Signal Transduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Succinates; Systole; Tetrazoles; Valine; Valsartan | 2014 |
Influence of carotid artery stenting on cognition of elderly patients with severe stenosis of the internal carotid artery.
Topics: Aged; Analysis of Variance; Angioplasty; Aspirin; Atorvastatin; Carotid Stenosis; China; Clopidogrel; Cognition; Female; Heptanoic Acids; Humans; Male; Pyrroles; Quality of Life; Regional Blood Flow; Stents; Ticlopidine; Treatment Outcome; Ultrasonography, Doppler, Transcranial | 2014 |
Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aspirin; Atorvastatin; Cardiovascular Agents; Cardiovascular Diseases; Clinical Protocols; Drug Combinations; Enalapril; Female; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iran; Male; Middle Aged; Polypharmacy; Primary Prevention; Research Design; Secondary Prevention; Sodium Chloride Symporter Inhibitors; Time Factors; Treatment Outcome; Valsartan | 2015 |
PolyPill for Prevention of Cardiovascular Disease in an Urban Iranian Population with Special Focus on Nonalcoholic Steatohepatitis: A Pragmatic Randomized Controlled Trial within a Cohort (PolyIran - Liver) - Study Protocol.
Topics: Angiotensin II Type 1 Receptor Blockers; Aspirin; Atorvastatin; Cardiovascular Diseases; Diuretics; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iran; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Platelet Aggregation Inhibitors; Urban Population; Valsartan | 2015 |
[IMPACT OF ATORVASTATIN AND ROSUVASTATIN ON RESIDUAL ON-CLOPIDOGREL TREATMENT PLATELET REACTIVITY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND TYPE 2 DIABETES MELLITUS AFTER ACUTE CORONARY SYNDROME].
Topics: Acute Coronary Syndrome; Aspirin; Atorvastatin; Blood Platelets; Clopidogrel; Diabetes Mellitus, Type 2; Drug Interactions; Drug Substitution; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Rosuvastatin Calcium; Ticlopidine | 2017 |
High-intensity Statin Treatments in Clinically Stable Patients on Aspirin Monotherapy 12 Months After Drug-eluting Stent Implantation: A Randomized Study.
Topics: Aspirin; Atorvastatin; Coronary Artery Disease; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Pravastatin; Stroke; Treatment Outcome | 2018 |
Low dose concomitant treatment with chlorpromazine and promethazine is safe in acute ischemic stroke.
Topics: Adult; Aged; Aspirin; Atorvastatin; Chlorpromazine; Double-Blind Method; Drug Therapy, Combination; Edaravone; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neuroprotective Agents; Platelet Aggregation Inhibitors; Promethazine; Stroke; Vinca Alkaloids | 2019 |
Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial.
Topics: Adult; Aged; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Blood Pressure; Cardiovascular Agents; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus; Drug Combinations; Enalapril; Female; Humans; Hydrochlorothiazide; Male; Medication Adherence; Middle Aged; Platelet Aggregation Inhibitors; Secondary Prevention; Valsartan | 2019 |
Pharmacodynamic study of the cardiovascular polypill. Is there any interaction among the monocomponents?
Topics: Aspirin; Atorvastatin; Cardiovascular Diseases; Cholesterol, LDL; Drug Combinations; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ramipril; Treatment Outcome | 2021 |
Effectiveness of Polypill for Prevention of Cardiovascular Disease (PolyPars): Protocol of a Randomized Controlled Trial.
Topics: Antihypertensive Agents; Aspirin; Atorvastatin; Cardiovascular Diseases; Drug Combinations; Female; Humans; Hydrochlorothiazide; Iran; Male; Middle Aged; Pragmatic Clinical Trials as Topic | 2020 |
Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
Topics: Adult; Aged; Aspirin; Atorvastatin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Host-Pathogen Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; India; Male; Middle Aged; Pandemics; Platelet Aggregation Inhibitors; Pneumonia, Viral; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Time Factors; Treatment Outcome | 2020 |
The Effect of Atorvastatin + Aspirin on the Endothelial Function Differs with Age in Patients with HIV: A Case-Control Study.
Topics: Aspirin; Atorvastatin; Brachial Artery; Carotid Arteries; Carotid Intima-Media Thickness; Case-Control Studies; Endothelium, Vascular; HIV Infections; Humans; Risk Factors; Ultrasonography; Vasodilation | 2021 |
A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.
Topics: Aspirin; Atorvastatin; COVID-19; Humans; India; Nicorandil; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome | 2021 |
Statin and aspirin as adjuvant therapy in hospitalised patients with SARS-CoV-2 infection: a randomised clinical trial (RESIST trial).
Topics: Aspirin; Atorvastatin; Clinical Deterioration; COVID-19 Drug Treatment; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; SARS-CoV-2; Treatment Outcome | 2022 |
Polypill Strategy in Secondary Cardiovascular Prevention.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Atorvastatin; Cardiovascular Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Stroke; Myocardial Infarction; Platelet Aggregation Inhibitors; Ramipril; Secondary Prevention | 2022 |
Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-risk TIA with intracranial or extracranial atherosclero
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Atorvastatin; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Ischemic Stroke; Middle Aged; Platelet Aggregation Inhibitors; Stroke | 2023 |
An open label randomized controlled trial of atorvastatin versus aspirin in elite controllers and antiretroviral-treated people with HIV.
Topics: Anti-Retroviral Agents; Aspirin; Atorvastatin; Cardiovascular Diseases; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Inflammation; Male; Middle Aged; Viral Load | 2023 |
104 other study(ies) available for aspirin and atorvastatin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Coronary revascularization and aggressive lipid lowering.
Topics: Aspirin; Atorvastatin; Coronary Stenosis; Heptanoic Acids; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Male; Metoprolol; Middle Aged; Myocardial Revascularization; Plasminogen Activators; Pyrroles; Risk Factors | 1999 |
Coronary artery spasm associated with a moderately severe atherosclerotic stenosis in the proximal LAD.
Topics: Adult; Aspirin; Atorvastatin; Cardiac Catheterization; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Vasospasm; Diltiazem; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heptanoic Acids; Humans; Isosorbide; Pyrroles; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome; Ultrasonography, Interventional | 2002 |
Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Aspirin; Atorvastatin; Biphenyl Compounds; Cholesterol, LDL; Coronary Disease; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Interleukin-6; Irbesartan; Isoquinolines; Male; Middle Aged; Monocytes; Platelet Aggregation Inhibitors; Pyrroles; Quinapril; Tetrahydroisoquinolines; Tetrazoles | 2003 |
Atorvastatin-clopidogrel interaction.
Topics: Aspirin; Atorvastatin; Clinical Trials as Topic; Clopidogrel; Confounding Factors, Epidemiologic; Drug Interactions; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Platelet Aggregation Inhibitors; Pyrroles; Ticlopidine | 2003 |
Statin use is associated with enhanced collateralization of severely diseased coronary arteries.
Topics: Aged; Aspirin; Atorvastatin; Calcium Channels; Collateral Circulation; Coronary Angiography; Coronary Disease; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Multivariate Analysis; Neovascularization, Pathologic; Pyrroles; Retrospective Studies | 2003 |
C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases.
Topics: Acute-Phase Reaction; Aspirin; Atorvastatin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Artery Disease; Heptanoic Acids; Humans; Incidence; Inflammation; Interleukin-6; Lovastatin; Pravastatin; Predictive Value of Tests; Pyrroles; Risk Factors; Simvastatin | 2004 |
Controversies in antiplatelet therapy for patients with cardiovascular disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Atorvastatin; Cardiovascular Diseases; Cyclooxygenase Inhibitors; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Heptanoic Acids; Humans; Platelet Aggregation Inhibitors; Pyrroles | 2005 |
Value for money in disease management of acute coronary syndrome--the price of aspirin to reduce the costs of ACS.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atorvastatin; Clinical Trials as Topic; Coronary Disease; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Pyrroles | 2005 |
Imaging of a regressive coronary soft plaque under lipid lowering therapy by multi-slice computed tomography.
Topics: Aspirin; Atorvastatin; Carotid Stenosis; Coronary Artery Disease; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Pyrroles; Radiography | 2006 |
Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Aspirin; Atorvastatin; Azoxymethane; Carcinogens; Celecoxib; Cell Growth Processes; Colonic Neoplasms; Dose-Response Relationship, Drug; Heptanoic Acids; Male; Pyrazoles; Pyrroles; Rats; Rats, Inbred F344; Sulfonamides | 2006 |
Single coronary artery with retroaortic course. An unusual origin of right Valsalva sinus.
Topics: Adult; Aspirin; Atorvastatin; Chest Pain; Coronary Vessel Anomalies; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Platelet Aggregation Inhibitors; Pyrroles; Radiography; Sinus of Valsalva; Vasodilator Agents; Verapamil | 2006 |
Effect of clopidogrel on the inflammatory progression of early atherosclerosis in rabbits model.
Topics: Animals; Aspirin; Atherosclerosis; Atorvastatin; Chemokine CCL2; Clopidogrel; Diet, Atherogenic; Disease Models, Animal; Femoral Artery; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Intercellular Adhesion Molecule-1; Male; P-Selectin; Platelet Aggregation Inhibitors; Pyrroles; Rabbits; Ticlopidine; Vascular Cell Adhesion Molecule-1 | 2007 |
Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atorvastatin; Biotin; Cyclooxygenase 2; Enzyme Induction; Heart; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Lipopolysaccharides; Lipoxins; Male; Myocardium; Nitroso Compounds; Pioglitazone; Pyrroles; Rats; Rats, Sprague-Dawley; Thiazolidinediones | 2007 |
Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Atorvastatin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Membrane Proteins; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Pyrroles; Rats; Rats, Sprague-Dawley | 2007 |
Aspirin and hormone therapy for prostate cancer.
Topics: Androgen Antagonists; Aspirin; Atorvastatin; Drug Therapy, Combination; Flutamide; Gonadotropin-Releasing Hormone; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Liver Function Tests; Logistic Models; Male; Prostatic Neoplasms; Pyrroles | 2007 |
Anti-inflammatory effects of combined treatment with acetyl salicylic acid and atorvastatin in haemodialysis patients affected by Normal Weight Obese syndrome.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Aspirin; Atorvastatin; Body Fat Distribution; Body Mass Index; Body Weight; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Inflammation; Kidney Failure, Chronic; Lipid Metabolism; Male; Middle Aged; Nutrition Assessment; Obesity; Prealbumin; Pyrroles; Renal Dialysis; Serum Albumin; Syndrome | 2008 |
LC and LC-MS methods for the investigation of polypills for the treatment of cardiovascular diseases. Part 1. Separation of active components and classification of their interaction/degradation products.
Topics: Aspirin; Atenolol; Atorvastatin; Cardiovascular Agents; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Drug Stability; Heptanoic Acids; Hydrochlorothiazide; Lisinopril; Pravastatin; Pyrroles; Simvastatin; Spectrometry, Mass, Electrospray Ionization | 2008 |
[Stroke due to spontaneous calcified cerebral embolus as presenting feature of calcified aortic stenosis].
Topics: Aged, 80 and over; Anterior Cerebral Artery; Aortic Valve; Aortic Valve Stenosis; Aspirin; Atorvastatin; Calcinosis; Heptanoic Acids; Humans; Intracranial Embolism; Male; Pyrroles; Stroke; Tomography, X-Ray Computed | 2008 |
Efficient tirofiban infusion resulting in resolution of intracoronary thrombus.
Topics: Anticholesteremic Agents; Aspirin; Atorvastatin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Therapy, Combination; Electrocardiography; Fibrinolytic Agents; Heptanoic Acids; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrroles; Ticlopidine; Tirofiban; Tyrosine | 2008 |
Serum uric acid level reduction, cardiovascular outcome, and mortality: comment on the article by Ioachimescu et al.
Topics: Anticholesteremic Agents; Aspirin; Atorvastatin; Cardiovascular Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Platelet Aggregation Inhibitors; Predictive Value of Tests; Pyrroles; Treatment Outcome; Uric Acid | 2008 |
Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
Topics: Aged; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Atorvastatin; Calcium Carbonate; Cardiomyopathy, Restrictive; Citalopram; Connective Tissue Diseases; Diuretics; Female; Furosemide; Glucosamine; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperpigmentation; Lupus Erythematosus, Systemic; Magnesium; Metolazone; Middle Aged; Naproxen; Omeprazole; Potassium Chloride; Prednisone; Pyrroles; Selective Serotonin Reuptake Inhibitors; Spironolactone | 2008 |
[Brain hypoperfusion revealed by an ocular ischemic syndrome].
Topics: Antihypertensive Agents; Aspirin; Atorvastatin; Brain Ischemia; Carotid Artery Thrombosis; Ciliary Body; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Ischemia; Light Coagulation; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Middle Aged; Ophthalmic Artery; Platelet Aggregation Inhibitors; Pyrroles; Recurrence; Stroke; Ultrasonography | 2008 |
Headache as the sole presenting symptom of acute myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Aspirin; Atorvastatin; Clopidogrel; Headache; Heparin, Low-Molecular-Weight; Heptanoic Acids; Humans; Male; Middle Aged; Myocardial Infarction; Oxygen Inhalation Therapy; Platelet Aggregation Inhibitors; Pyrroles; Ticlopidine | 2009 |
The role of transcranial Doppler embolic monitoring in the management of intracranial arterial stenosis.
Topics: Angiography, Digital Subtraction; Aspirin; Atorvastatin; Blood Flow Velocity; Cerebral Angiography; Clopidogrel; Constriction, Pathologic; Diagnosis, Differential; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Embolism; Ischemic Attack, Transient; Magnetic Resonance Imaging; Platelet Aggregation Inhibitors; Pyrroles; Ticlopidine; Tomography, X-Ray Computed; Ultrasonography, Doppler, Transcranial; Young Adult | 2011 |
Approach to the patient who is intolerant of statin therapy.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Atorvastatin; Coronary Disease; Diltiazem; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Middle Aged; Pyrroles; Simvastatin | 2010 |
The inhibitory effect of statins on urinary 11-dehydrothromboxane levels.
Topics: Aged; Aspirin; Atorvastatin; Biomarkers; Blood Glucose; Blood Platelets; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Czech Republic; Down-Regulation; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrroles; Simvastatin; Thromboxane B2; Time Factors; Treatment Outcome; Triglycerides | 2010 |
[Case of branch atheromatous disease presenting capsular warning syndrome].
Topics: Anticoagulants; Aspirin; Atherosclerosis; Atorvastatin; Dextrans; Diffusion Magnetic Resonance Imaging; Drug Therapy, Combination; Heptanoic Acids; Humans; Infusions, Intravenous; Ischemic Attack, Transient; Magnetic Resonance Angiography; Male; Middle Aged; Pyrroles; Recurrence; Syndrome; Thrombolytic Therapy; Tissue Plasminogen Activator | 2010 |
Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression.
Topics: Aspirin; Atorvastatin; Case-Control Studies; Confidence Intervals; Cytokines; Depressive Disorder, Major; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Middle Aged; Models, Psychological; Pravastatin; Pyrroles; Retrospective Studies; Risk Factors; Simvastatin; Time Factors | 2010 |
TIAs - management in general practice.
Topics: Anticoagulants; Antihypertensive Agents; Aspirin; Atorvastatin; Clopidogrel; Dipyridamole; Dopamine Antagonists; General Practitioners; Heptanoic Acids; Humans; Hypolipidemic Agents; Ischemic Attack, Transient; Perindopril; Platelet Aggregation Inhibitors; Primary Health Care; Prochlorperazine; Pyrroles; Ticlopidine; Vasodilator Agents; Warfarin | 2010 |
Fabry disease and Factor V Leiden: a potent vascular risk combination.
Topics: Activated Protein C Resistance; alpha-Galactosidase; Aspirin; Atorvastatin; Coronary Stenosis; Defibrillators, Implantable; Drug Therapy, Combination; Enzyme Replacement Therapy; Fabry Disease; Factor V; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Metoprolol; Middle Aged; Perindopril; Pyrroles; Quality of Life; Recurrence; Sequence Deletion; Stents; Stroke; Stroke Rehabilitation; Thrombophilia; Warfarin | 2011 |
Recurrent ischemic stroke in a patient with ulcerative colitis and high levels of lipoprotein (a).
Topics: Anticholesteremic Agents; Anticoagulants; Aspirin; Atorvastatin; Blood Coagulation Tests; Carotid Stenosis; Clopidogrel; Colitis, Ulcerative; Female; Heparin, Low-Molecular-Weight; Heptanoic Acids; Humans; Lipoprotein(a); Magnetic Resonance Imaging; Middle Aged; Pyrroles; Risk Factors; Stroke; Thrombosis; Ticlopidine; Ultrasonography | 2011 |
Atorvastatin and clopidogrel interfere with photosensitization in vitro.
Topics: Animals; Anticholesteremic Agents; Aspirin; Atorvastatin; Cathepsin B; Cell Line; Clopidogrel; Heptanoic Acids; Humans; Light; Macrophages; Mice; Neoplasms; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Polylysine; Porphyrins; Pyrroles; Ticlopidine | 2011 |
Simultaneous estimation of ramipril, acetylsalicylic acid and atorvastatin calcium by chemometrics assisted UV-spectrophotometric method in capsules.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Calibration; Capsules; Chemistry, Pharmaceutical; Heptanoic Acids; Humans; Least-Squares Analysis; Models, Theoretical; Pyrroles; Ramipril; Regression Analysis; Reproducibility of Results; Spectrophotometry, Ultraviolet | 2011 |
Small unruptured partially thrombosed aneurysms and stroke: report of three cases and review of the literature.
Topics: Aspirin; Atorvastatin; Craniotomy; Echocardiography, Transesophageal; Fibrinolytic Agents; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infarction, Middle Cerebral Artery; Intracranial Aneurysm; Intracranial Embolism; Male; Middle Aged; Neurosurgical Procedures; Paresis; Pyrroles; Stroke; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2012 |
Pravastatin and simvastatin improves acetylsalicylic acid-mediated in vitro blood platelet inhibition.
Topics: Adult; Aspirin; Atorvastatin; Blood Platelets; Cholesterol; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Pravastatin; Pyrroles; Simvastatin; Young Adult | 2012 |
Buerger's disease (Thromboangiitis obliterans): a diagnostic challenge.
Topics: Adult; Angiography; Aspirin; Atorvastatin; Calcium Channel Blockers; Drug Therapy, Combination; Heparin, Low-Molecular-Weight; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iloprost; Male; Nifedipine; Pentoxifylline; Platelet Aggregation Inhibitors; Pyrroles; Smoking Cessation; Thromboangiitis Obliterans | 2011 |
A rare case of a coronary vascular ring arising from an anomalous single coronary artery.
Topics: Aged; Aspirin; Atorvastatin; Coronary Angiography; Coronary Vessel Anomalies; Drug Therapy, Combination; Female; Follow-Up Studies; Heptanoic Acids; Humans; Pyrroles; Rare Diseases; Risk Assessment; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Capsular warning syndrome caused by spontaneous middle cerebral artery dissection.
Topics: Angiography, Digital Subtraction; Aspirin; Atorvastatin; Brain Ischemia; Cerebral Angiography; Diffusion Magnetic Resonance Imaging; Echocardiography; Electrocardiography; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Processing, Computer-Assisted; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged; Middle Cerebral Artery; Platelet Aggregation Inhibitors; Pyrroles; Smoking | 2012 |
Bilateral posterior cerebral artery infarction.
Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Confusion; Dominance, Cerebral; Drug Therapy, Combination; Fibrinolytic Agents; Hemianopsia; Heptanoic Acids; Humans; Infarction, Posterior Cerebral Artery; Magnetic Resonance Imaging; Male; Memory Disorders; Memory, Short-Term; Perindopril; Pyrroles; Tomography, X-Ray Computed | 2010 |
Sudden bilateral anterior cerebral infarction: unusual stroke associated with unusual vascular anomalies.
Topics: Adult; Aspirin; Atorvastatin; Carotid Artery Diseases; Carotid Artery, Internal; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infarction, Anterior Cerebral Artery; Magnetic Resonance Angiography; Male; Platelet Aggregation Inhibitors; Pyrroles; Stroke | 2013 |
Long-term results of plaque excision combined with aggressive pharmacotherapy in high-risk patients with advanced peripheral artery disease (SAVE a LEG registry).
Topics: Adult; Aged; Aged, 80 and over; Amputation, Surgical; Aspirin; Atherectomy; Atorvastatin; Cardiovascular Agents; Clopidogrel; Combined Modality Therapy; Critical Illness; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Intermittent Claudication; Ischemia; Kaplan-Meier Estimate; Limb Salvage; Male; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Pyrroles; Recurrence; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Ticlopidine; Time Factors; Treatment Outcome | 2013 |
Devic syndrome: can antiphospholipid antibodies be a factor?
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Antirheumatic Agents; Aspirin; Atorvastatin; Azathioprine; Complement C4; Cyclophosphamide; Female; Glucocorticoids; Heparin; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin G; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Plasmapheresis; Prednisolone; Pulse Therapy, Drug; Pyrroles; Warfarin | 2012 |
Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms.
Topics: Anticholesteremic Agents; Aspirin; Atorvastatin; Blood Platelets; Calcium; Collagen; Cyclooxygenase 1; Drug Combinations; Drug Synergism; Heptanoic Acids; Humans; Mitogen-Activated Protein Kinases; Phospholipase A2 Inhibitors; Phospholipases A2; Phosphorylation; Platelet Aggregation; Pravastatin; Pyrroles; Simvastatin; Thromboxane A2; Thromboxane-A Synthase | 2013 |
Asymptomatic carotid stenosis.
Topics: Aged; Amlodipine; Anticholesteremic Agents; Aspirin; Asymptomatic Diseases; Atorvastatin; Azetidines; Carotid Stenosis; Diet, Mediterranean; Drug Therapy, Combination; Exercise Therapy; Ezetimibe; Female; Heptanoic Acids; Humans; Perindopril; Pyrroles; Risk; Stroke; Treatment Outcome; Ultrasonography; Vasodilator Agents | 2013 |
Cerebral infarction in a case of Parry-Romberg syndrome.
Topics: Adult; Aspirin; Atorvastatin; Cerebral Infarction; Diffusion Magnetic Resonance Imaging; Facial Hemiatrophy; Female; Fibrinolytic Agents; Foramen Ovale, Patent; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Risk Factors; Treatment Outcome | 2014 |
Secondary prevention of atherothrombotic or cryptogenic stroke.
Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Clopidogrel; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Life Style; Platelet Aggregation Inhibitors; Pyrroles; Recurrence; Risk Factors; Secondary Prevention; Stroke; Ticlopidine | 2014 |
Comparative study of three modified numerical spectrophotometric methods: an application on pharmaceutical ternary mixture of aspirin, atorvastatin and clopedogrel.
Topics: Aspirin; Atorvastatin; Clopidogrel; Heptanoic Acids; Pyrroles; Spectrophotometry; Ticlopidine | 2014 |
A calcified left ventricular mass.
Topics: Aged, 80 and over; Aging; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Calcinosis; Diagnosis, Differential; Female; Heart Neoplasms; Heart Valve Diseases; Heptanoic Acids; Humans; Hypertension; Mitral Valve; Monitoring, Physiologic; Platelet Aggregation Inhibitors; Pyrroles; Quinapril; Radiography; Tetrahydroisoquinolines; Treatment Outcome | 2014 |
[Analysis of clinical use of shuxuening injection in treatment of cerebral infarction based on real world].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atorvastatin; Cerebral Infarction; Drugs, Chinese Herbal; Female; Heptanoic Acids; Humans; Male; Middle Aged; Piperazines; Pyrroles; Young Adult | 2014 |
Liquid Chromatographic Method for Simultaneous Quantitation of Clopidogrel, Aspirin and Atorvastatin in Rat Plasma and Its Application to the Pharmacokinetic Study.
Topics: Animals; Anticholesteremic Agents; Aspirin; Atorvastatin; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Clopidogrel; Limit of Detection; Male; Platelet Aggregation Inhibitors; Rats; Reproducibility of Results; Ticlopidine | 2015 |
New approach application of data transformation in mean centering of ratio spectra method.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Aspirin; Atorvastatin; Clopidogrel; Normal Distribution; Platelet Aggregation Inhibitors; Spectrophotometry; Ticlopidine | 2015 |
Recurrent ischaemic stroke unveils polycythaemia vera.
Topics: Aspirin; Atorvastatin; Bloodletting; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Platelet Aggregation Inhibitors; Polycythemia Vera; Pyrroles; Recurrence; Stroke; Treatment Outcome | 2015 |
Design of a Dissolving Microneedle Platform for Transdermal Delivery of a Fixed-Dose Combination of Cardiovascular Drugs.
Topics: Administration, Cutaneous; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Aspirin; Atorvastatin; Cardiovascular Agents; Chemistry, Pharmaceutical; Drug Combinations; Drug Delivery Systems; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Lisinopril; Microinjections; Platelet Aggregation Inhibitors; Swine | 2015 |
Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy.
Topics: Adenosine; Aged; Aspirin; Atorvastatin; Chi-Square Distribution; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Polypharmacy; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Ticagrelor; Ticlopidine; Treatment Outcome | 2015 |
Clinicians' Reports in Electronic Health Records Versus Patients' Concerns in Social Media: A Pilot Study of Adverse Drug Reactions of Aspirin and Atorvastatin.
Topics: Adverse Drug Reaction Reporting Systems; Aspirin; Atorvastatin; Drug-Related Side Effects and Adverse Reactions; Electronic Health Records; Exanthema; Humans; Musculoskeletal Pain; Physician's Role; Pilot Projects; Social Media | 2016 |
Spontaneous coronary artery dissection in the presence of myocardial bridge causing myocardial infarction: an insight into mechanism.
Topics: Adult; Aspirin; Atorvastatin; Clopidogrel; Coronary Angiography; Coronary Vessel Anomalies; Female; Humans; Myocardial Bridging; Myocardial Infarction; Perindopril; Ticlopidine; Treatment Outcome; Vascular Diseases | 2016 |
Atorvastatin (Lipitor) attenuates the effects of aspirin on pancreatic cancerogenesis and the chemotherapeutic efficacy of gemcitabine on pancreatic cancer by promoting M2 polarized tumor associated macrophages.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antimetabolites, Antineoplastic; Aspirin; Atorvastatin; Cell Line; Cell Proliferation; Deoxycytidine; Drug Synergism; Gemcitabine; Gene Expression Regulation, Neoplastic; Macrophages; Male; Mice; Pancreatic Neoplasms; Xenograft Model Antitumor Assays | 2016 |
[Polypill for secondary coronary heart disease prevention].
Topics: Aspirin; Atorvastatin; Cardiovascular Agents; Coronary Disease; Drug Combinations; Humans; Medication Adherence; Ramipril | 2015 |
A Step Ahead in Secondary Prevention of Cardiovascular Risk. Consensus Document on Clinical Use of the Polypill.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Atorvastatin; Cardiovascular Diseases; Drug Combinations; Europe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Medication Adherence; Patient Selection; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Ramipril; Secondary Prevention; Spain | 2016 |
[Combination drug improves adherence].
Topics: Aspirin; Atorvastatin; Capsules; Cardiovascular Agents; Coronary Disease; Drug Combinations; Humans; Ramipril; Secondary Prevention | 2016 |
Protective Effect of Guggulipid in High Fat Diet and Middle Cerebral Artery Occlusion (MCAO) Induced Ischemic Cerebral Injury in Rats.
Topics: Animals; Aspirin; Atorvastatin; Brain; Brain Ischemia; Catalase; Commiphora; Diet, High-Fat; Drug Therapy, Combination; Female; Glutathione; Hand Strength; Infarction, Middle Cerebral Artery; Lipid Peroxidation; Locomotion; Male; Neuroprotective Agents; Phytotherapy; Plant Extracts; Plant Gums; Rats; Superoxide Dismutase | 2016 |
Usefulness of a Cardiovascular Polypill in the Treatment of Secondary Prevention Patients in Spain: A Cost-effectiveness Study.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Atorvastatin; Cardiovascular Diseases; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Female; Follow-Up Studies; Forecasting; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Markov Chains; Medication Adherence; Middle Aged; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Ramipril; Retrospective Studies; Secondary Prevention; Spain | 2017 |
In Silico and Wet Lab Studies Reveal the Cholesterol Lowering Efficacy of Lauric Acid, a Medium Chain Fat of Coconut Oil.
Topics: Animals; Aspirin; Atorvastatin; Cholesterol; Coconut Oil; Dose-Response Relationship, Drug; Fatty Acids; Hydroxymethylglutaryl CoA Reductases; Hypolipidemic Agents; Lauric Acids; Male; Models, Animal; Molecular Docking Simulation; Plant Oils; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sterol Esterase; Triglycerides | 2016 |
Combined effects of atorvastatin and aspirin on growth and apoptosis in human prostate cancer cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Apoptosis; Aspirin; Atorvastatin; Blotting, Western; Cell Proliferation; Drug Therapy, Combination; Extracellular Signal-Regulated MAP Kinases; Humans; Immunoenzyme Techniques; Male; Mice; Mice, SCID; NF-kappa B; Phosphorylation; Prostatic Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2017 |
Simultaneous Determination of Acetylsalicylic Acid, Hydrochlorothiazide, Enalapril, and Atorvastatin in a Polypill-Based Quaternary Mixture by TLC.
Topics: Aspirin; Atorvastatin; Cardiotonic Agents; Chromatography, Thin Layer; Densitometry; Drug Compounding; Enalapril; Hydrochlorothiazide; Limit of Detection; Reproducibility of Results | 2018 |
Lights Out: An Unusual Case of Amaurosis Fugax.
Topics: Amaurosis Fugax; Angiography, Digital Subtraction; Anticholesteremic Agents; Arterial Occlusive Diseases; Aspirin; Atorvastatin; Brachiocephalic Trunk; Clopidogrel; Computed Tomography Angiography; Drug Therapy, Combination; Female; Humans; Middle Aged; Platelet Aggregation Inhibitors; Stents; Stroke; Vertigo | 2018 |
[Real world analysis to explore clinical features of Shenxiong glucose injection combined with other medications].
Topics: Aspirin; Atorvastatin; China; Drug Therapy, Combination; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; Platelet Aggregation Inhibitors; Pulmonary Heart Disease | 2017 |
Unilateral Thalamic Infarct Presenting as a Convulsive Seizure.
Topics: Aspirin; Atorvastatin; Cerebral Angiography; Cerebral Infarction; Humans; Hydrocephalus; Levetiracetam; Magnetic Resonance Angiography; Male; Middle Aged; Piracetam; Seizures; Thalamus | 2017 |
[Drug combination characteristics of Shenxiong glucose injection in treating ischemic cerebrovascular disease in real world].
Topics: Aspirin; Atorvastatin; Cerebrovascular Disorders; China; Clopidogrel; Drug Therapy, Combination; Drugs, Chinese Herbal; Ginkgo biloba; Hospital Information Systems; Humans; Ischemia; Medicine, Chinese Traditional; Plant Extracts | 2017 |
Internal Carotid Artery Web as the Cause of Recurrent Cryptogenic Ischemic Stroke.
Topics: Adult; Aspirin; Atorvastatin; Biopsy; Brain Ischemia; Cardiovascular Agents; Carotid Artery Diseases; Carotid Artery, Internal; Computed Tomography Angiography; Female; Fibromuscular Dysplasia; Humans; Hyperplasia; Neointima; Recurrence; Risk Factors; Stroke | 2018 |
Can aldosterone break your heart? Takotsubo cardiomyopathy in a patient with newly diagnosed primary aldosteronism.
Topics: Aldosterone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Chest Pain; Coronary Angiography; Electrocardiography; Female; Humans; Hyperaldosteronism; Hypertension; Metoprolol; Middle Aged; Takotsubo Cardiomyopathy; Treatment Outcome | 2018 |
Artery of Percheron: an unusual stroke presentation.
Topics: Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Aspirin; Atorvastatin; Cerebral Arteries; Clopidogrel; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Vascular Malformations | 2018 |
DEVELOPMENT OF COMPRESSED COATED POLYPILL WITH MUCOADHESIVE CORE COMPRISING OF ATORVASTATIN/CLOPIDOGREL/ASPIRIN USING COMPRESSION COATING TECHNIQUE.
Topics: Acrylates; Adhesiveness; Administration, Oral; Animals; Aspirin; Atorvastatin; Carboxymethylcellulose Sodium; Chemistry, Pharmaceutical; Clopidogrel; Delayed-Action Preparations; Drug Combinations; Drug Compounding; Drug Liberation; Hydrogen-Ion Concentration; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypromellose Derivatives; Intestinal Mucosa; Kinetics; Models, Chemical; Platelet Aggregation Inhibitors; Polymers; Polypharmacy; Rabbits; Solubility; Surface Properties; Tablets, Enteric-Coated; Technology, Pharmaceutical; Ticlopidine | 2017 |
Irradiation-Induced Cardiac Connexin-43 and miR-21 Responses Are Hampered by Treatment with Atorvastatin and Aspirin.
Topics: Animals; Antioxidants; Aspirin; Atorvastatin; Connexin 43; Heart; Male; MicroRNAs; Myocardium; Radiation Injuries; Radiation, Ionizing; Rats; Rats, Wistar | 2018 |
Anterior spinal cord infarct: a rare yet disabling stroke.
Topics: Aged, 80 and over; Aspirin; Atorvastatin; Clopidogrel; Diagnosis, Differential; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Platelet Aggregation Inhibitors; Rare Diseases; Spinal Cord; Spinal Cord Ischemia; Stroke; Stroke Rehabilitation; Ticlopidine; Treatment Outcome | 2018 |
Targeting NLRP3 inflammasome via acetylsalicylic acid: Role in suppressing hepatic dysfunction and insulin resistance induced by atorvastatin in naïve versus alcoholic liver in rats.
Topics: Alcoholism; Animals; Aspirin; Atorvastatin; Bile Acids and Salts; Caspase 8; Hepatocytes; Inflammasomes; Insulin Resistance; Liver; Liver Function Tests; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Perfusion; Rats, Wistar; Staining and Labeling; Sulfobromophthalein | 2018 |
Ischemic stroke following a wasp sting - a rare complication: a case report.
Topics: Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Aspirin; Atorvastatin; Brain; Brain Ischemia; Humans; Insect Bites and Stings; Magnetic Resonance Imaging; Male; Stroke; Wasps | 2018 |
Possible association of influenza A infection and reverse takotsubo syndrome.
Topics: Acute Coronary Syndrome; Aged; Antiviral Agents; Aspirin; Atorvastatin; Chest Pain; Coronary Angiography; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Influenza A virus; Influenza, Human; Oseltamivir; Platelet Aggregation Inhibitors; Takotsubo Cardiomyopathy; Treatment Outcome | 2018 |
Simultaneous transient global amnesia and Takotsubo syndrome after death of a relative: a case report.
Topics: Amnesia, Transient Global; Antihypertensive Agents; Aspirin; Atorvastatin; Benzimidazoles; Biphenyl Compounds; Bisoprolol; Coronary Angiography; Electrocardiography; Fibrinolytic Agents; Grief; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Middle Aged; Myocarditis; Stress, Psychological; Takotsubo Cardiomyopathy; Tetrazoles; Treatment Outcome | 2019 |
Twenty-and-a-half syndrome: a case report.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atorvastatin; Brain; Brain Ischemia; Cranial Nerve Diseases; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Middle Aged; Paresis; Physical Therapy Modalities; Platelet Aggregation Inhibitors; Ramipril; Stroke; Syndrome | 2019 |
Comparison of the Neuroprotective Effects of Aspirin, Atorvastatin, Captopril and Metformin in Diabetes Mellitus.
Topics: Animals; Aspirin; Atorvastatin; Captopril; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Male; Metformin; Neuroprotective Agents; Rats; Rats, Wistar; Streptozocin | 2019 |
CADASIL with Large Intracranial Arterial Atherosclerotic Stenosis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atorvastatin; CADASIL; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Arteriosclerosis; Magnetic Resonance Imaging; Male; Microscopy, Electron, Scanning; Middle Cerebral Artery | 2019 |
Delusional parasitosis as presenting symptom of occipital lobe cerebrovascular accident.
Topics: Anticholesteremic Agents; Aspirin; Atorvastatin; Delusional Parasitosis; Female; Humans; Middle Aged; Neuroimaging; Occipital Lobe; Pruritus; Stroke; Treatment Outcome | 2019 |
Atorvastatin and Conditioned Media from Atorvastatin-Treated Human Hematopoietic Stem/Progenitor-Derived Cells Show Proangiogenic Activity
Topics: AC133 Antigen; Antigens, CD34; Aspirin; Atorvastatin; Cells, Cultured; Culture Media, Conditioned; Hematopoietic Stem Cells; Heme Oxygenase-1; Humans; Immunoassay; Isothiocyanates; Leukocytes, Mononuclear; Metformin; Neovascularization, Physiologic; Phenotype; Resveratrol; Sulfoxides | 2019 |
Kinking of Bilateral Internal Carotid Arteries as Cause of Cognitive Dysfunction.
Topics: Anticholesteremic Agents; Aspirin; Atorvastatin; Bosnia and Herzegovina; Bromazepam; Carotid Artery, Internal; Citalopram; Clopidogrel; Cognitive Dysfunction; Donepezil; Dopamine Agents; Fibrinolytic Agents; GABA Modulators; Humans; Male; Memantine; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2020 |
Postexercise Ankle-Brachial Index Testing.
Topics: Ankle Brachial Index; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Exercise; Exercise Test; Exercise Therapy; Female; Humans; Intermittent Claudication; Lisinopril; Middle Aged; Peripheral Arterial Disease | 2020 |
Caught in a Flare.
Topics: Arthralgia; Aspirin; Atorvastatin; Brain; Diagnosis, Differential; Exanthema; Fatigue; Female; Hematologic Tests; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Nervous System Diseases; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Young Adult | 2020 |
Acute bilateral cerebral infarction in the presence of neuromyelitis optica spectrum disorder: A case report.
Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Anticholesteremic Agents; Aphasia, Broca; Aspirin; Atorvastatin; Benzofurans; Cerebral Infarction; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Neuroprotective Agents; Plasmapheresis; Platelet Aggregation Inhibitors; Treatment Outcome | 2020 |
Use of the Cardiovascular Polypill in Secondary Prevention of Cerebrovascular Disease: A Real-Life Tertiary Hospital Cohort Study of 104 Patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Atorvastatin; Cerebrovascular Disorders; Drug Combinations; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Medication Adherence; Middle Aged; Platelet Aggregation Inhibitors; Ramipril; Recurrence; Retrospective Studies; Secondary Prevention; Tablets; Tertiary Care Centers; Time Factors; Treatment Outcome | 2020 |
Effects of atorvastatin and aspirin on post-stroke epilepsy and usage of levetiracetam.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Aspirin; Atorvastatin; Cerebral Infarction; Drug Therapy, Combination; Epilepsy; Female; Humans; Levetiracetam; Male; Severity of Illness Index; Stroke | 2020 |
2019 novel coronavirus disease with secondary ischemic stroke: two case reports.
Topics: Aspirin; Atorvastatin; Brain Ischemia; COVID-19; Fibrinolytic Agents; Humans; Ischemic Stroke; Male; Middle Aged; Pandemics; SARS-CoV-2; Tirofiban | 2021 |
Anabolic steroid use and ischaemic stroke in a young fitness enthusiast.
Topics: Administration, Intravenous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Aspirin; Atorvastatin; Brain Ischemia; Clomiphene; Doping in Sports; Echocardiography; Estrogen Antagonists; Exercise; Heart Septal Defects, Atrial; Humans; Ischemic Stroke; Male; Tamoxifen; Testosterone Congeners | 2021 |
Human ES and iPS cells display less drug resistance than differentiated cells, and naïve-state induction further decreases drug resistance.
Topics: Amiodarone; Animals; Aspirin; Atorvastatin; Cell Differentiation; Cell Line; Clotrimazole; Drug Resistance; Drug Resistance, Multiple; Embryonic Stem Cells; Humans; Induced Pluripotent Stem Cells | 2021 |
Implications of Ezetimibe in Combination with Low- to Moderate-Intensity Atorvastatin Adjuvant Aspirin Therapy for Cerebrovascular Disease.
Topics: Activities of Daily Living; Anticholesteremic Agents; Aspirin; Atorvastatin; C-Reactive Protein; Carotid Intima-Media Thickness; Cerebrovascular Disorders; Cholesterol, LDL; Ezetimibe; Humans; Leptin; Pyrroles; Treatment Outcome; Triglycerides | 2022 |
Identification of target and pathway of aspirin combined with Lipitor treatment in prostate cancer through integrated bioinformatics analysis.
Topics: Aspirin; Atorvastatin; Cell Cycle Proteins; Computational Biology; DNA Primase; Gene Expression Regulation, Neoplastic; Humans; Male; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Protein Serine-Threonine Kinases | 2022 |
Effects of Long-Term Intervention with Losartan, Aspirin and Atorvastatin on Vascular Remodeling in Juvenile Spontaneously Hypertensive Rats.
Topics: Animals; Antihypertensive Agents; Aspirin; Atorvastatin; Blood Pressure; Collagen; Hypertension; Interleukin-6; Losartan; Rats; Rats, Inbred SHR; Renin; Vascular Remodeling | 2023 |
Multicomponent spectrophotometric determination of a ternary mixture of widely-prescribed cardiovascular drugs by four different methods.
Topics: Aspirin; Atorvastatin; Cardiovascular Agents; Humans; Ramipril; Spectrophotometry | 2023 |
Effects of long-term regular oral aspirin combined with atorvastatin to prevent ischemic stroke on human gut microbiota.
Topics: Aspirin; Atorvastatin; Cross-Sectional Studies; Gastrointestinal Microbiome; Humans; Ischemic Stroke; RNA, Ribosomal, 16S | 2023 |
Atorvastatin Effect on Clopidogrel Efficacy in Patients with Peripheral Artery Disease.
Topics: Anticoagulants; Aspirin; Atorvastatin; Clopidogrel; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine; Treatment Outcome; Venous Thromboembolism | 2023 |